Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 10/20 | 0.37 |
| ▸ | PPARA | Q07869 | 10/20 | 0.37 |
| ▸ | PPARD | Q03181 | 3/20 | 0.37 |
| ▸ | SLC16A3 | O15427 | 3/20 | 0.31 |
| ▸ | SLC16A1 | P53985 | 3/20 | 0.31 |
| ▸ | MCTS1 | Q9ULC4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4929653 | 0.94 | PPARG (0.35) | PPARGPPARAPPARDSLC16A3SLC16A1 | |
| SCHEMBL4929643 | 0.94 | PPARG (0.35) | PPARGPPARAPPARDSLC16A3SLC16A1 | |
| SCHEMBL4388895 | 0.91 | PPARA (0.34) | PPARGPPARAPPARD | |
| SCHEMBL4382592 | 0.91 | PPARA (0.34) | PPARGPPARAPPARD | |
| SCHEMBL4391936 | 0.89 | PPARG (0.33) | PPARGPPARAPPARD | |
| SCHEMBL4391942 | 0.89 | PPARG (0.35) | PPARGPPARAPPARDSLC16A3SLC16A1 | |
| SCHEMBL4375526 | 0.89 | PPARG (0.35) | PPARGPPARAPPARDSLC16A3SLC16A1 | |
| SCHEMBL4377292 | 0.85 | PPARA (0.40) | PPARGPPARAPPARDSLC16A3SLC16A1 | |
| SCHEMBL4380128 | 0.82 | PPARA (0.44) | PPARGPPARAPPARD | |
| SCHEMBL4384708 | 0.81 | PPARA (0.42) | PPARGPPARAPPARDSLC16A3SLC16A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1789402-B1 | 2-{-3-2-(PHENYL)-OXAZOL-4-YLMETHOXYMETHYL!-CYCLOHEXYLMETHOXY };-PROPIONIC ACID DERIVATIVES USED AS PPAR LIGANDES (PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS) FOR THE TREATMENT OF HYPERLIPIDAEMIE AND DIABETES | SANOFI AVENTIS DEUTSCHLAND (DE) | 2009-11-18 | — | — | EP | disclosed |